Shares Investor Evening (Edinburgh)
Wednesday 12 September 2018
Come and join Shares and AJ Bell Media at their Edinburgh Investor Evening on Wednesday 12 September 2018 at the Radisson Blu Hotel, located in the heart of the historic Royal Mile.
Our Edinburgh evening event provides an opportunity for Board Directors, from dynamic companies that are listed on the London Stock Exchange, to make presentations and talk about their company's business plans for the rest of 2018, to existing & potential new investors.
During the event and afterwards over drinks and food, attendees will have the chance to get to know the companies better by talking one on one with the company directors.
Attend the Edinburgh event on 12 September 2018 and you will receive a bottle of Champagne and a ‘Shares’ Sports Flip Lid Water Bottle.
Mercia Technologies (MERC) is a national investment group focused on the funding and scaling of innovative businesses with high growth potential from the UK regions. Initially this is through Mercia's managed funds and then selectively scaling businesses through its own balance sheet capital.
SkinBioTherapeutics (SBTX) is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company is targeting three specific skin healthcare sectors; cosmetics, infection control and eczema.
Tekcapital (TEK) is a UK IP investment group focused on creating market value from university technology. They accomplish this by acquiring, enhancing and developing bright new discoveries from their network of over 4,500 universities and research centres in 160 countries.
Thor Mining (THR) is an exploration and development company with an advanced tungsten/molybdenum project poised for development, a growing tungsten resource, and an exciting copper development project.
VolitionRx is a multi-national life sciences company focused on developing simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers. The tests are based on the technology platform of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present.
Who Should Attend
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Registration and coffee
Dr. Mark Payton, CEO - Mercia Asset Management (MERC)
Dr. Catherine O'Neill, CEO - SkinBioTherapeutics (SBTX)
Malcolm Groat, FD - Tekcapital (TEK)
Michael Billing, Executive Chairman & CEO - Thor Mining (THR)
Cameron Reynolds, President & CEO - Volition Diagnostics
Drinks reception and canapés
Radisson Blu Hotel Edinburgh